NCT06227039

Brief Summary

In-office procedures (IOPs) are a cost-effective, and safe alternative to many operating room procedure, with benefits such as reduced anesthesia risk. One of the major causes of failed in-office procedures or requirement of conversion to the operating room is poor patient tolerance. Vibration and augmented reality (AR) can be used as non-pharmacologic treatment options to treat patient anxiety and pain by using the physiology proposed by the gate-way theory of pain as well as distraction. This study seeks to compare anxiety and pain perception with patient reported survey data, as well as physiologic indicators of stress such as heart rate variability (HRV) within patients undergoing IOPs in a laryngology office with and without vibration and AR treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 26, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 26, 2024

Status Verified

January 1, 2024

Enrollment Period

2.3 years

First QC Date

January 17, 2024

Last Update Submit

January 17, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • Max pain experienced

    Visual analog scale rating of max perceived pain during procedure

    measured post-treatment (1 hr).

  • Average pain experienced

    Visual analog scale rating of average perceived pain during procedure

    measured post-treatment (1 hr).

  • Pain nervousness experienced

    Visual analog scale rating of how nervous about pain patient was during procedure

    measured post-treatment (1 hr).

  • Time spent thinking about pain

    Visual analog scale rating of percent of time spent thinking about pain during procedure

    measured post-treatment (1 hr).

  • Change in heart rate variability during procedure

    Difference between heart rate variability during procedure compared with pre-procedure

    calculated post-treatment (1 hr).

  • Change in maximum heart rate

    Difference between maximum heart rate during procedure compared with pre-procedure

    calculated post-treatment (1 hr).

  • Change in average heart rate

    Difference between average heart rate during procedure compared with pre-procedure

    calculated post-treatment (1 hr).

Secondary Outcomes (3)

  • Change is STAI score

    calculated post-procedure (1 hr).

  • Pain catastrophizing score

    calculated pre-procedure (1 hr).

  • Patient satisfaction

    measured post-treatment (1 hr).

Study Arms (4)

No treatment

NO INTERVENTION

This arm will be the current standard of care

Vibroacoustic

EXPERIMENTAL

This arm will use the vibroacoustic device to provide a mechanical stimulus to the patient as treatment to reduce pain and anxiety. Augmented reality glasses will be worn but will be turned off.

Other: Vibroacoustic stimulation onOther: Augmented reality off

Augmented Reality

EXPERIMENTAL

This arm will use the augmented reality game to provide a visual stimulus to the patient as treatment to reduce pain and anxiety. Vibroacoustic device will be worn but will be turned off.

Other: Augmented Reality onOther: Vibroacoustic stimulation off

Combination vibroacoustic and augmented reality

EXPERIMENTAL

This arm will use both the augmented reality game and vibroacoustic device to provide a visual stimulus to the patient as treatment to reduce pain and anxiety.

Other: Vibroacoustic stimulation onOther: Augmented Reality on

Interventions

Mechanical stimulus is provided to the patient through a vibroacoustic device via vibration around the neck.

Combination vibroacoustic and augmented realityVibroacoustic

Visual stimulus is provided through augmented reality glasses in the form of a game.

Augmented RealityCombination vibroacoustic and augmented reality

Vibroacoustic device is worn but turned off.

Augmented Reality

Augmented reality glasses are worn but turned off.

Vibroacoustic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing office-based laryngology procedure performed at home institution.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UVA Fontaine Research Park Building 415

Charlottesville, Virginia, 22903, United States

RECRUITING

Related Publications (13)

  • McCarthy M. US health-care system faces cost and insurance crises. Rising costs, growing numbers of uninsured, and quality gaps trouble world's most expensive health-care system. Lancet. 2003 Aug 2;362(9381):375. doi: 10.1016/s0140-6736(03)14057-3. No abstract available.

    PMID: 12907006BACKGROUND
  • Rice T, Rosenau P, Unruh LY, Barnes AJ, Saltman RB, van Ginneken E. United States of America: health system review. Health Syst Transit. 2013;15(3):1-431.

    PMID: 24025796BACKGROUND
  • Hoffer EP. The American Health Care System Is Broken. Part 7: How Can We Fix It? Am J Med. 2019 Dec;132(12):1381-1385. doi: 10.1016/j.amjmed.2019.10.003. Epub 2019 Oct 24.

    PMID: 31668898BACKGROUND
  • Young S, Shapiro FE, Urman RD. Office-based surgery and patient outcomes. Curr Opin Anaesthesiol. 2018 Dec;31(6):707-712. doi: 10.1097/ACO.0000000000000655.

    PMID: 30148715BACKGROUND
  • Saini AT, Citardi MJ, Yao WC, Luong AU. Office-Based Sinus Surgery. Otolaryngol Clin North Am. 2019 Jun;52(3):473-483. doi: 10.1016/j.otc.2019.02.003. Epub 2019 Mar 22.

    PMID: 30905564BACKGROUND
  • Shah PD. Patient Safety and Quality for Office-Based Procedures in Otolaryngology. Otolaryngol Clin North Am. 2019 Feb;52(1):89-102. doi: 10.1016/j.otc.2018.08.015. Epub 2018 Sep 22.

    PMID: 30249445BACKGROUND
  • Braz J, Solorzano C, Wang X, Basbaum AI. Transmitting pain and itch messages: a contemporary view of the spinal cord circuits that generate gate control. Neuron. 2014 May 7;82(3):522-36. doi: 10.1016/j.neuron.2014.01.018.

    PMID: 24811377BACKGROUND
  • Treede RD. Gain control mechanisms in the nociceptive system. Pain. 2016 Jun;157(6):1199-1204. doi: 10.1097/j.pain.0000000000000499.

    PMID: 26817644BACKGROUND
  • Zhang Y, Liu S, Zhang YQ, Goulding M, Wang YQ, Ma Q. Timing Mechanisms Underlying Gate Control by Feedforward Inhibition. Neuron. 2018 Sep 5;99(5):941-955.e4. doi: 10.1016/j.neuron.2018.07.026. Epub 2018 Aug 16.

    PMID: 30122375BACKGROUND
  • Smith KC, Comite SL, Balasubramanian S, Carver A, Liu JF. Vibration anesthesia: a noninvasive method of reducing discomfort prior to dermatologic procedures. Dermatol Online J. 2004 Oct 15;10(2):1.

    PMID: 15530291BACKGROUND
  • Mally P, Czyz CN, Chan NJ, Wulc AE. Vibration anesthesia for the reduction of pain with facial dermal filler injections. Aesthetic Plast Surg. 2014 Apr;38(2):413-8. doi: 10.1007/s00266-013-0264-4. Epub 2014 Jan 24.

    PMID: 24464122BACKGROUND
  • Sharma P, Czyz CN, Wulc AE. Investigating the efficacy of vibration anesthesia to reduce pain from cosmetic botulinum toxin injections. Aesthet Surg J. 2011 Nov;31(8):966-71. doi: 10.1177/1090820X11422809. Epub 2011 Oct 14.

    PMID: 22001341BACKGROUND
  • Legrain V, Damme SV, Eccleston C, Davis KD, Seminowicz DA, Crombez G. A neurocognitive model of attention to pain: behavioral and neuroimaging evidence. Pain. 2009 Aug;144(3):230-232. doi: 10.1016/j.pain.2009.03.020. Epub 2009 Apr 18. No abstract available.

    PMID: 19376654BACKGROUND

MeSH Terms

Conditions

Acute PainVocal Cord ParalysisLaryngeal Neoplasms

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesVagus Nerve DiseasesCranial Nerve DiseasesNervous System DiseasesParalysisOtorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsRespiratory Tract Neoplasms

Study Officials

  • James J Daniero, MD

    University of Virginia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

James J Daniero, MD

CONTACT

Elena Miller, MPH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Division Director, Laryngology and Voice Care

Study Record Dates

First Submitted

January 17, 2024

First Posted

January 26, 2024

Study Start

October 1, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

January 26, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

There is no intention to share individual participant data with other researchers.

Locations